📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: TomegaVax

1.1 - Company Overview

TomegaVax Logo

TomegaVax

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of an immunotherapy vaccine technology platform focused on preclinical and clinical development of vaccines and immunotherapies for chronic and recurring viral infections, including HIV and HPV, addressing unmet medical needs and pursuing cures for AIDS, herpes, papillomavirus and hepatitis.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to TomegaVax

InflaRx Logo

InflaRx

HQ: Germany Website
  • Description: Provider of therapeutics for acute and chronic inflammation targeting the C5a/C5aR pathway, including vilobelimab, a monoclonal antibody for chronic inflammatory diseases, oncology and critically ill COVID-19, authorized for emergency use by the FDA in hospitalized adults requiring invasive mechanical ventilation or ECMO, and INF904, an oral C5aR inhibitor in development for chronic spontaneous urticaria and hidradenitis suppurativa.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full InflaRx company profile →
Tizona Therapeutics Logo

Tizona Therapeutics

HQ: United States Website
  • Description: Provider of next-generation immunotherapies, including TTX-080, an investigational antibody targeting HLA-G evaluated as monotherapy and in combination in patients with advanced cancers; TTX-030, a monoclonal antibody inhibiting CD39 studied with an approved anti-PD-1 agent and standard chemotherapy in adults with advanced cancer; and TZ-040, a pre-clinical program anticipated to enter IND-enabling studies targeting novel immuno-modulatory molecules.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Tizona Therapeutics company profile →
Delenex Therapeutics Logo

Delenex Therapeutics

HQ: Switzerland Website
  • Description: Provider of therapeutic antibody fragments targeting serious medical diseases with high unmet need, designed for local/topical application to deliver the benefits of antibody therapy with limited systemic exposure, built on clinically validated technology.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Delenex Therapeutics company profile →
Hepion Pharmaceuticals Logo

Hepion Pharmaceuticals

HQ: United States Website
  • Description: Provider of clinical-stage biopharmaceutical drug development, featuring rencofilstat, a cyclophilin inhibitor aimed at reducing liver fibrosis and hepatocellular carcinoma tumor burden, currently in Phase 2 for NASH, and a proprietary AI/ML platform to understand disease processes and identify patients who respond to rencofilstat, potentially shortening development timelines and enhancing clinical trial outcomes.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Hepion Pharmaceuticals company profile →
Outlook Therapeutics Logo

Outlook Therapeutics

HQ: United States Website
  • Description: Provider of biopharmaceutical development focused on ophthalmic formulations.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Outlook Therapeutics company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for TomegaVax

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to TomegaVax

2.2 - Growth funds investing in similar companies to TomegaVax

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for TomegaVax

4.2 - Public trading comparable groups for TomegaVax

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to TomegaVax

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About TomegaVax

What does TomegaVax do?

TomegaVax is a provider of an immunotherapy vaccine technology platform focused on preclinical and clinical development of vaccines and immunotherapies for chronic and recurring viral infections, including HIV and HPV, addressing unmet medical needs and pursuing cures for AIDS, herpes, papillomavirus and hepatitis.

Who are TomegaVax's competitors?

TomegaVax's competitors and similar companies include InflaRx, Tizona Therapeutics, Delenex Therapeutics, Hepion Pharmaceuticals, and Outlook Therapeutics.

Where is TomegaVax headquartered?

TomegaVax is headquartered in United States.

How many employees does TomegaVax have?

TomegaVax has 1,000 employees 🔒.

When was TomegaVax founded?

TomegaVax was founded in 2010 🔒.

What sector and industry vertical is TomegaVax in?

TomegaVax is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for TomegaVax

Who are the top strategic acquirers in TomegaVax's sector and industry

Top strategic M&A buyers and acquirers in TomegaVax's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for TomegaVax?

Top strategic M&A buyers groups and sectors for TomegaVax include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in TomegaVax's sector and industry vertical

Which are the top PE firms investing in TomegaVax's sector and industry vertical?

Top PE firms investing in TomegaVax's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in TomegaVax's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in TomegaVax's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in TomegaVax's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to TomegaVax include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in TomegaVax's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for TomegaVax?

The key public trading comparables and valuation benchmarks for TomegaVax include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for TomegaVax for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for TomegaVax with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in TomegaVax's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for TomegaVax with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in TomegaVax's' sector and industry vertical?

Access recent funding rounds and capital raises in TomegaVax's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for TomegaVax